New Article – Pharmaceutical & Biotech Lifecycle Management (II) – non-innovator patents
In my new article, (the 2nd in a series on Pharmaceutical & Biotech Lifecycle Management), I look at how early non-innovators are filing patents covering new drug products (very early) and some of the strategic ramifications. For those who like data – the article is accompanied by a couple of slides showing the data points.
I look forward to your thoughts.
(The first article in the series looked at whether generic products are being launched earlier than ever and some implications.)
You must log in to post a comment.